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In the previous issue of Critical Care, Možina and 
Podbregar report that changes in thenar muscle tissue 
saturation (StO2) in response to vascular occlusion can be 
used to predict discrepancy between central (ScvO2) and 
mixed (SvO2) venous oxygen saturation in patients with 
combined severe left ventricular failure and sepsis [1].
On ﬁ   rst read this study is conceptually diﬃ   cult. 
Essentially, ScvO2 is a surrogate marker of SvO2 and is 
widely used to assess adequacy of oxygen delivery, and to 
guide the initial resuscitation of septic patients [2]. 
Trends in ScvO2 may reﬂ  ect those in SvO2, but alterations 
in oxygen extraction and redistribution of blood ﬂ  ow 
away from peripheral and splanchnic circulations in 
various shock states may cause clinically important 
diﬀ  er  ences between these values [3]. In these circum-
stances ScvO2 may be maintained despite abnormally low 
SvO2 and signiﬁ  cant tissue hypoxia. Th  e current study 
suggests a means to identify these discrepancies which 
may be useful in the management of sepsis/septic shock, 
particularly in patients with complex haemodynamic 
distur  bances. However, several issues relating to 
methodo  logical factors require further consideration.
Microcirculatory perfusion and tissue oxygen utiliza-
tion are aﬀ  ected by sepsis and shock [4]. Th  ese  derange-
ments can be studied non-invasively using near-infrared 
spectroscopy, a technique that is able to determine the 
oxygenation status of tissue haemoglobin. Decreased 
StO2 reﬂ  ects the presence of severe hypoperfusion and 
has been used clinically to guide resuscitation during 
hypovolaemic shock [5]. Unfortunately, in sepsis/septic 
shock absolute values of StO2 do not reliably diﬀ  erentiate 
patients from healthy individuals [6].
Th   e discriminatory power and predictive ability of StO2
can, however, be improved by measuring the response to 
an ischaemic challenge. Th  e vascular occlusion test 
(VOT) is a provocative test in which StO2 is measured at 
a peripheral site (such as the thenar eminence) whilst a 
transient rapid vascular occlusion is performed for either 
a deﬁ  ned time interval or until a pre-deﬁ  ned StO2 value is 
reached. Th   e VOT-derived StO2 trace can be divided into 
four phases - baseline, ischemia, reperfusion, and 
hyperemia - and parameters can be measured for each of 
these. Th  ese include: rate of deoxygenation (DeO2), 
measured from the StO2 downslope during the ischaemic 
phase - this is generally considered to reﬂ  ect local muscle 
metabolism and mitochondrial oxygen consumption [7]; 
and rate of reoxygenation (ReO2), measured from the 
StO2 upslope during reperfusion - this is the time 
required to wash out stagnant blood and is thought to 
reﬂ  ect the reactivity of the microcirculation [8].
Studies suggest that the response to the VOT diﬀ  ers in 
sepsis, with a slower DeO2 during cuﬀ   occlusion and a 
prolonged ReO2 during reperfusion when compared to 
healthy individuals [9,10]. Furthermore, it seems that 
VOT reﬂ   ects severity of illness and is sensitive to 
intervention with activated protein C [8,11]. According 
Abstract
Sepsis and shock result in disturbances in 
microcirculatory perfusion and tissue oxygen utilisation 
that may not be refl  ected in global measures of 
haemodynamics. Near-infrared spectroscopy enables 
measurement of tissue oxygen saturation (StO2) 
and provides information on local microvascular 
and mitochondrial function. This measure could be 
incorporated with existing targets of goal-directed 
therapy to provide an integrated approach to 
haemodynamic resuscitation of both the macro- and 
microcirculation in various shock states. However, key 
methodological factors must be addressed before 
widespread clinical application.
© 2010 BioMed Central Ltd
Tissue saturation measurement - exciting 
prospects, but standardisation and reference data 
still needed
Nicola Jones1 and Marius Terblanche1,2*
See related research by Možina and Podbregar, http://ccforum.com/content/14/2/R42
COMMENTARY
*Correspondence: marius.terblanche@kcl.ac.uk
1Department of Critical Care Medicine, Guy’s and St Thomas’ NHS Foundation Trust, 
London SE1 7EH, UK
Full list of author information is available at the end of the article
Jones and Terblanche Critical Care 2010, 14:169 
http://ccforum.com/content/14/3/169
© 2010 BioMed Central Ltdto the current study it may also have a role in guiding 
resuscitation and optimisation of haemodynamics.
Th  ese  ﬁ  ndings are exciting, but at present enthusiasm 
must be tempered. Firstly, there are wide variations in 
StO2 and VOT-derived parameters dependent upon 
probe position and probe size [12]. Secondly, the VOT 
procedure has yet to be standardized; currently, diﬀ  erent 
types and degrees of deﬂ  ation thresholds (for example, 
absolute StO2 of 40% or 50% versus duration of 3 minutes, 
4 minutes, 5 minutes) are employed [13]. Th  irdly, 
context-speciﬁ  c ranges for VOT-derived StO2 parameters 
need to be estab  lished in health to ensure correct 
interpretation of responses in pathological states. High 
quality data are also needed on the VOT parameter 
values for diﬀ  erent levels of disease severity, and indeed 
for diﬀ  erent diseases. Finally, the mechanisms underlying 
diﬀ  erences in StO2 response observed in sepsis need to 
be fully characterized.
Dynamic StO2 monitoring is a promising technique 
with the potential to provide a non-invasive ‘biopsy’ of 
microvascular and mitochondrial function. Used in 
conjunc  tion with global measures of oxygen delivery it 
could provide an integrated approach to haemodynamic 
resuscitation of both the macro- and microcirculation in 
various shock states. Furthermore, it may have utility in 
determining disease severity, outcome prediction, 
assessment of the biological eﬀ  ects of interventions, and 
in guiding future research. However, as with all new 
technologies it is essential that operating characteristics 
are robustly deﬁ   ned and that the limitations are fully 
appreciated before wider application to the clinical 
setting.
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